Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Interventional
×
Fever
×
dabrafenib
×
Clear all
Filters
3
NCT01972347
2025-12-16
Neo Combi
Melanoma Institute Australia
Phase 2
Active not recruiting
35 enrolled
NCT03551626
2025-04-29
COMBI-APlus
Novartis
Phase 3
Completed
552 enrolled
12 charts